血管内皮生长因子及其受体对巨核细胞和血小板的影响及相关疾病
综述阐述血管内皮生长因子(VEGFs)及其受体(VEGFRs)在巨核细胞(MKs)和血小板中的表达与功能,以及VEGF-VEGFR环路在骨髓增殖性肿瘤、骨髓增生异常综合征和急性巨核细胞白血病中的异常表达,提示靶向该环路可能具有潜在治疗价值。
要点
- VEGFs及VEGFRs在巨核细胞不同发育阶段差异表达并发挥自分泌、旁分泌等调控作用。
- VEGF-VEGFR环路在骨髓增殖性肿瘤、骨髓增生异常综合征和急性巨核细胞白血病中异常表达。
- 靶向VEGF-VEGFR环路可能具有潜在治疗价值。
核心结论
- VEGFs及其受体在巨核细胞相关疾病中异常表达,导致骨髓细胞增殖分化紊乱和血管生成,靶向VEGF-VEGFR环路可能具有潜在治疗价值。
研究设计与样本
- 综述,检索范围原文未报告。
主要发现
- 造血干细胞、巨核细胞系、培养的巨核细胞、原代巨核细胞及异常巨核细胞均表达和分泌VEGFs。
- 从造血干细胞向巨核细胞发育过程中,VEGFR1、VEGFR2和VEGFR3分别在不同发育阶段表达并再表达(如VEGFR2),通过自分泌、旁分泌甚至胞内分泌环路在定植、分化、增殖、存活和多倍体化中发挥不同作用。
- VEGFs及其受体在骨髓增殖性肿瘤、骨髓增生异常综合征和急性巨核细胞白血病(急性髓系白血病的罕见亚型)中异常表达。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
It is well known that vascular endothelial growth factors (VEGFs) and their receptors (vascular endothelial growth factor receptors, VEGFRs) are expressed in different tissues, and VEGF-VEGFR loops regulate a wide range of responses, including metabolic homeostasis, cell proliferation, migration and tubuleogenesis. As ligands, VEGFs act on three structurally related VEGFRs (VEGFR1, VEGFR2 and VEGFR3 [also termed FLT1, KDR and FLT4, respectively]) that deliver downstream signals. Haematopoietic stem cells (HSCs), megakaryocytic cell lines, cultured megakaryocytes (MKs), primary MKs and abnormal MKs express and secrete VEGFs. During the development from HSCs to MKs, VEGFR1, VEGFR2 and VEGFR3 are expressed at different developmental stages, respectively, and re-expressed, e.g., VEGFR2, and play different roles in commitment, differentiation, proliferation, survival and polyplodization of HSCs/MKs via autocrine, paracrine and/or even intracrine loops. Moreover, VEGFs and their receptors are abnormally expressed in MK-related diseases, including myeloproliferative neoplasms, myelodysplastic syndromes and acute megakaryocytic leukaemia (a rare subtype of acute myeloid leukaemia), and they lead to the disordered proliferation/differentiation of bone marrow cells and angiogenesis, indicating that they are closely related to these diseases. Thus, targeting VEGF-VEGFR loops may be of potential therapeutic value.
引用
- Yang JG, Wang LL, Ma DC, et al. Effects of vascular endothelial growth factors and their receptors on megakaryocytes and platelets and related diseases. Br J Haematol. 2017. PMID: 29076133. doi:10.1111/bjh.15000
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。